Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Auci

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|August 1, 1997
Methylphenidate and the immune systemD L Auci, S Fikrig, J Rodriquez
Immunological Investigations|July 1, 1992
Dysregulated proteolysis in AIDSD L Auci, H G Durkin, M R Murali
Immunological Investigations|April 1, 1994
IL-6 mediated isotype specific suppression of hapten specific IgE in serum of BPO-KLH sensitized mice: role of IFN alpha in maintainance of hapten specific IgE responsesD L Auci, H Miller, S M Chice, et al.
Immunopharmacology|September 1, 1993
Control of IgE responses. II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutideD L Auci, S M Chice, P Dukor, et al.
Journal of Leukocyte Biology|September 1, 1992
Constitutive production of PAI-II and increased surface expression of GM1 ganglioside by peripheral blood monocytes from patients with AIDS: evidence of monocyte activation in vivoD L Auci, S M Chice, H G Durkin, et al.
Journal of Leukocyte Biology|January 1, 1995
Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitroJ A Carucci, D L Auci, C A Herrick, et al.
Journal of Leukocyte Biology|May 1, 1996
IFN-alpha-mediated suppression of low-affinity FC(epsilon) receptors on Peyer's patch lymphocytes and augmentation of soluble CD23: implications for IgE responsesH Miller, M H Bluth, S M Chice, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1992
Origin and fate of IgE-bearing lymphocytes. II. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-keyhole limpet hemocyanin by various routes: relation to asialo GM1 ganglioside+ cells and IgE/CD23 immune complexesD L Auci, S M Chice, C Heusser, et al.
Regional Immunology|July 1, 1992
Peyer's patches and mesenteric lymph nodes are the sites of first appearance of IgE bearing B lymphocytes and hapten specific IgE antibody forming cells in BPO-KLH sensitized miceD L Auci, S M Chice, C Heusser, et al.
Journal of Leukocyte Biology|August 1, 1993
Suppression of human IgE antibody forming cell responses by IL-6G I Kleiner, D L Auci, A Shaikh, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Child and Adolescent Psychiatry|August 1, 1997
Methylphenidate and the immune systemD L Auci, S Fikrig, J Rodriquez
Immunological Investigations|July 1, 1992
Dysregulated proteolysis in AIDSD L Auci, H G Durkin, M R Murali
Immunological Investigations|April 1, 1994
IL-6 mediated isotype specific suppression of hapten specific IgE in serum of BPO-KLH sensitized mice: role of IFN alpha in maintainance of hapten specific IgE responsesD L Auci, H Miller, S M Chice, et al.
Immunopharmacology|September 1, 1993
Control of IgE responses. II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutideD L Auci, S M Chice, P Dukor, et al.
Journal of Leukocyte Biology|September 1, 1992
Constitutive production of PAI-II and increased surface expression of GM1 ganglioside by peripheral blood monocytes from patients with AIDS: evidence of monocyte activation in vivoD L Auci, S M Chice, H G Durkin, et al.
Journal of Leukocyte Biology|January 1, 1995
Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitroJ A Carucci, D L Auci, C A Herrick, et al.
Journal of Leukocyte Biology|May 1, 1996
IFN-alpha-mediated suppression of low-affinity FC(epsilon) receptors on Peyer's patch lymphocytes and augmentation of soluble CD23: implications for IgE responsesH Miller, M H Bluth, S M Chice, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1992
Origin and fate of IgE-bearing lymphocytes. II. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-keyhole limpet hemocyanin by various routes: relation to asialo GM1 ganglioside+ cells and IgE/CD23 immune complexesD L Auci, S M Chice, C Heusser, et al.
Regional Immunology|July 1, 1992
Peyer's patches and mesenteric lymph nodes are the sites of first appearance of IgE bearing B lymphocytes and hapten specific IgE antibody forming cells in BPO-KLH sensitized miceD L Auci, S M Chice, C Heusser, et al.
Journal of Leukocyte Biology|August 1, 1993
Suppression of human IgE antibody forming cell responses by IL-6G I Kleiner, D L Auci, A Shaikh, et al.
Pageof 2